The very first study publication worldwide with our LEXO® was conducted at the REHA ZENTRUM MÜNSTER, Austria. The study offers valuable insights into patients´ needs and identifies necessary adjustments to ensure that robot-assisted gait training is both enjoyable and effective for patients. The results create a better understanding of robot-assisted gait training with an end-effector device in general and with the LEXO® in specific.
The mixed-methods feasibility study aimed to explore the feasibility, acceptability, goal attainment, and preliminary effects of robot-assisted gait training in patients with common and rare neurological diseases. Twenty-eight patients with stroke, multiple sclerosis, Parkinson´s disease, spinal cord injury, spinocerebellar ataxia, acute/chronic inflammatory demyelinating polyneuropathy, and motor neuron disease were included in the study. Patients received robot-assisted gait training on the LEXO® for 45 minutes, 4x/week, for 4 weeks.
Study highlights:
- LEXO® training was highly accepted by patients with various neurological diseases, feasible, and safe.
- Goal attainment was high as well as results showed overall and clinically meaningful changes in walking.
- Improvements in number of steps, walking speed, and functional mobility were observed.
Read more about LEXO®: https://tyromotion.com/en/products/lexo/
Hotz I, Mildner S, Stampfer-Kountchev M, Slamik B, Blättner C, Türtscher E, Kübler F, Höfer C, Panzl J, Rücker M, Brenneis C, Seebacher B. Robot-assisted gait training in patients with various neurological diseases: A mixed methods feasibility study. PLoS One. 2024 Aug 27;19(8):e0307434.